Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Clinical trial NCT00899353 · TERMINATED

Trial details

NCT number: NCT00899353
Sponsor: Marshall University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Monoclonal Gammopathy of Undetermined Significance Smoldering Multiple Myeloma Chronic Lymphocytic Leukemia

Start date: 2008-08-01
Primary completion: 2011-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.